- Home
- SST vs DARE Comparison
SST vs DARE Comparison
Compare SST & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- DARE
- Stock Information
- Founded
- SST 2013
- DARE 2015
- Country
- SST United States
- DARE United States
- Employees
- SST N/A
- DARE N/A
- Industry
- SST Diversified Commercial Services
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- SST Consumer Discretionary
- DARE Health Care
- Exchange
- SST Nasdaq
- DARE Nasdaq
- Market Cap
- SST 23.3M
- DARE 26.3M
- IPO Year
- SST N/A
- DARE N/A
- Fundamental
- Price
- SST $5.74
- DARE $1.96
- Analyst Decision
- SST Strong Buy
- DARE Strong Buy
- Analyst Count
- SST 1
- DARE 3
- Target Price
- SST $10.00
- DARE $12.50
- AVG Volume (30 Days)
- SST 59.2K
- DARE 4.3M
- Earning Date
- SST 08-07-2025
- DARE 08-14-2025
- Dividend Yield
- SST N/A
- DARE N/A
- EPS Growth
- SST N/A
- DARE N/A
- EPS
- SST N/A
- DARE N/A
- Revenue
- SST $317,055,000.00
- DARE $25,909.00
- Revenue This Year
- SST N/A
- DARE $74,787.57
- Revenue Next Year
- SST $8.39
- DARE $141.76
- P/E Ratio
- SST N/A
- DARE N/A
- Revenue Growth
- SST N/A
- DARE N/A
- 52 Week Low
- SST $2.90
- DARE $1.83
- 52 Week High
- SST $15.30
- DARE $9.19
- Technical
- Relative Strength Index (RSI)
- SST 44.70
- DARE 26.59
- Support Level
- SST $4.95
- DARE $1.83
- Resistance Level
- SST $6.31
- DARE $2.50
- Average True Range (ATR)
- SST 0.70
- DARE 0.14
- MACD
- SST -0.18
- DARE -0.06
- Stochastic Oscillator
- SST 23.06
- DARE 8.25
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.